Table 2.
Select attributes of crash report forms pertinent to linked analyses with prescription drug monitoring program data (n=51)a
| Attribute | N (%) |
|---|---|
| Year of last crash report form update | |
| 2005-2009 | 16 (31) |
| 2010-2014 | 23 (45) |
| 2015-2018 | 12 (24) |
| Field to document whether drugs were suspected b | |
| Yes | 30 (59) |
| Unknown or not mentioned | 21 (41) |
| Field to document type of drug test administered b | |
| Yes | 43 (84) |
| Unknown or not mentioned | 8 (16) |
| Detail of drug test result documentation b,c | |
| Positive or negative indication for drug involvement | 28 (55) |
| Drugs selected from a pre-defined list | 11 (22) |
| Narrative, supplemental document, or drug recognition expert report | 4 (8) |
| Unknown or not mentioned | 8 (16) |
| Field for whether prescription or illicit drugs involved b | |
| Yes | 33 (65) |
| Unknown or not mentioned | 18 (35) |
a
Includes 50 U.S. states and the District of Columbia
b
Documents whether a field is available on crash report form to capture these elements; completeness varies by state.
c
Generally captured in terms of broad categories; see Appendix for specific information by state.
Note: State laws and practices may vary with respect to release of data for linkage and research purposes and is an important state-specific consideration.